Quarterly report pursuant to Section 13 or 15(d)

REVENUES (Tables)

v3.22.2
REVENUES (Tables)
6 Months Ended
Jun. 30, 2022
REVENUES  
Schedule of revenues disaggregated by category

Revenues disaggregated by category were as follows (in thousands):

Three Months Ended June 30, 

Six Months Ended June 30, 

2022

    

2021

2022

    

2021

Product sales:

Gross product sales

$

26,427

$

22,037

$

49,045

38,146

Discounts and allowances

(7,877)

(4,984)

(14,298)

(8,717)

Total product sales, net

18,550

17,053

34,747

29,429

Revenues from collaborations:

License revenues

2,337

3,305

2,545

67,923

Development milestones

5,000

5,000

Research and development services and others

3,932

408

4,262

1,432

Total revenues from collaborations

11,269

3,713

11,807

69,355

Government contract

5,500

8,500

Total revenues

$

29,819

$

26,266

$

46,554

$

107,284

Schedule of product revenue allowance and reserve categories

Chargebacks,

Government

Discounts and

and Other

Fees

Rebates

Returns

Total

Balance as of January 1, 2022

    

$

3,404

$

2,494

$

2,017

$

7,915

Provision related to current period sales

9,680

2,711

613

13,004

Credit or payments made during the period

(7,748)

(2,901)

(39)

(10,688)

Balance as of June 30, 2022

 

$

5,336

$

2,304

$

2,591

$

10,231

Chargebacks,

Government

Discounts and

and Other

Fees

Rebates

Returns

Total

Balance as of January 1, 2021

    

$

2,461

 

$

2,115

$

1,489

$

6,065

Provision related to current period sales

4,589

2,710

483

7,782

Credit or payments made during the period

(4,800)

(2,433)

(293)

(7,526)

Balance as of June 30, 2021

 

$

2,250

$

2,392

$

1,679

$

6,321

Schedule of revenues from product sales disaggregated by customers

The following table summarizes the percentages of revenues from each of our customers who individually accounted for 10% or more (wherein * denotes less than 10%) of the total net product sales and revenues from collaborations:

Three Months Ended June 30, 

Six Months Ended June 30, 

2022

    

2021

2022

    

2021

McKesson Specialty Care Distribution Corporation

34%

33%

36%

13%

Kissei

25%

*

16%

*

Cardinal Healthcare

16%

13%

20%

*

ASD Healthcare and Oncology Supply

12%

36%

19%

13%

Lilly

*

16%

*

65%